These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. II. E-CR1 levels in patients with various diseases and their correlation with B-CR1]. Itoh Y; Fukunaga Y; Yamamoto M Arerugi; 1989 Nov; 38(11):1276-87. PubMed ID: 2534036 [TBL] [Abstract][Full Text] [Related]
7. Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Cosio FG; Shen XP; Hebert LA Clin Immunol Immunopathol; 1990 Jun; 55(3):337-54. PubMed ID: 2140304 [TBL] [Abstract][Full Text] [Related]
8. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy. Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542 [TBL] [Abstract][Full Text] [Related]
9. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b. Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215 [TBL] [Abstract][Full Text] [Related]
10. A simple method for accurate quantification of complement receptor 1 on erythrocytes preserved by fixing or freezing. Cockburn IA; Donvito B; Cohen JH; Rowe JA J Immunol Methods; 2002 Dec; 271(1-2):59-64. PubMed ID: 12445729 [TBL] [Abstract][Full Text] [Related]
15. [The structure and role of CR1 complement receptor in physiology]. Rochowiak A; Niemir ZI Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis. Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD Complement; 1986; 3(2):88-96. PubMed ID: 2945697 [TBL] [Abstract][Full Text] [Related]
17. Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria. Tetteh-Quarcoo PB; Schmidt CQ; Tham WH; Hauhart R; Mertens HD; Rowe A; Atkinson JP; Cowman AF; Rowe JA; Barlow PN PLoS One; 2012; 7(4):e34820. PubMed ID: 22506052 [TBL] [Abstract][Full Text] [Related]
19. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms. Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335 [TBL] [Abstract][Full Text] [Related]
20. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease. de Carvalho Lins CE; Pereira Crott LS; Teixeira JE; Barbosa JE Lupus; 2004; 13(7):517-21. PubMed ID: 15352423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]